Combination of benzothiazol-2-one beta2 adrenoceptor agonists and corticosteroids for the treatment of respiratory diseases

Details for Australian Patent Application No. 2005210140 (hide)

Owner Novartis Pharma AG

Inventors Fairhurst, Robin Alec

Agent Davies Collison Cave

Pub. Number AU-A-2005210140

PCT Pub. Number WO2005/074924

Priority 0402797.5 09.02.04 GB

Filing date 8 February 2005

Wipo publication date 18 August 2005

International Classifications

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/573 (2006.01)

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/074924 Priority application(s): WO2005/074924

25 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210142-Method for producing conjugates of polysaccharides and polynucleotides

2005210137-Combination of (a) a DNA topoisomerase inhibitor and (b) an IAP inhibitor